Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2016-09-06 | New | $525,000 | $525,000 | Equity Only | 06b | SEC link |
| 2015-08-26 | New | $0 | $0 | Equity Only | 06b | SEC link |
| 2013-12-03 | New | $125,000 | $125,000 | Equity Only | 06b | SEC link |
| 2011-09-28 | Amended | $2,327,500 | $1,227,500 | Equity Only | 06 | SEC link |
| 2011-08-19 | New | $1,100,000 | $1,100,000 | Equity Only | 06 | SEC link |
| 2010-11-16 | Amended | $2,012,121 | $897,121 | Equity Only | 06 | SEC link |
| 2010-08-11 | New | $1,115,000 | $1,115,000 | Equity Only | 06 | SEC link |
| 2010-02-16 | New | $273,178 | $273,178 | Equity Only | 06 | SEC link |
| 2009-08-13 | New | $439,400 | Unknown | Equity Only | 06 | SEC link |
| 2008-08-18 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2007-01-16 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| Scott Allocco | Director |
| Paul Beresford | Director |
| Sam Broder | Director |
| Cy Cabradilla | Executive |
| Douglas Clark | Director |
| Jack Davis | Director |
| Joseph Klein | Director |
| Katarzyna Kusmierz | Director |
| Glenn Miller | Director |
| Karen Olson | Director, Executive, Promoter |
| Jerry Parrott | Director, Executive |
| Jason Rubin | Director |
| Mark Velleca | Director |
| Christine Wyskiel | Director |
| Christina Wyskiel | Director, Executive |